A Seven-Marker Signature and Clinical Outcome in Malignant Melanoma: A Large-Scale Tissue-Microarray Study with Two Independent Patient Cohorts
Figure 6
Validation of the Seven-Marker Signature and the FDR Marker Selection Procedure.
Kaplan-Meier estimates of overall (Panel A) and recurrence-free survival (Panel B) for the independent external test cohort of 225 patients (TMA 2) confirm the predictive prognostic power of the signature (p<0.001).